scholarly journals Comparison of long term clinical outcomes between bare metal stent versus different types of drug eluting stents for treatment of acute myocardial infarction

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. 2593-2593
Author(s):  
J. H. Choi ◽  
H. W. Lee ◽  
T. J. Hong ◽  
K. S. Cha ◽  
J. H. Oh ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Clinical Outcomes ◽  
Bare Metal Stent ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Metal Stent ◽  
Different Types ◽  
Drug Eluting

scholarly journals Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety?

2009 ◽  
Vol 30 (15) ◽  
pp. 1828-1830 ◽  
Author(s):  
A. V. Finn ◽  
G. Nakazawa ◽  
F. Kolodgie ◽  
R. Virmani
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Bare Metal Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Drug Eluting

scholarly journals Long-term adverse outcomes associated with drug-eluting stents and bare-metal stent in patients with small coronary artery disease: a systematic review and meta-analysis

2018 ◽  
Vol 15 (1) ◽  
pp. 1-7
Author(s):  
Nabin Chaudhary ◽  
Pravesh Kumar Bundhun ◽  
Sujan Shrestha ◽  
He Yan
Keyword(s):  
Coronary Artery Disease ◽  
Meta Analysis ◽  
Bare Metal Stent ◽  
Adverse Outcomes ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Metal Stent ◽  
Drug Eluting ◽  
Artery Disease

Objective: The main purpose of this meta-analysis was to compare the long-term adverse outcomes associated with drug-eluting stents (DES) and bare-metal stent (BMS) in patients with small coronary artery disease (CAD).Method: Randomized Controlled Trials (RCTs) and observational studies comparing the adverse outcomes such as mortality, major adverse cardiovascular events (MACE), myocardial infarction (MI), stent thrombosis (ST), target lesion revascularization (TLR), target vessel revascularization (TVR), and restenosis in small CAD patients receiving DES and BMS were searched from Embase, PubMed, and Cochrane Library databases. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated and the pooled analyses were performed with RevMan 5.3.Result: A total number of 4,106 patients with small CAD (2,123 patients received DES and 1,983 patients received BMS) have been included in this meta-analysis. Pool-analysis demonstrated that the risk of mortality, MACE, MI, ST, TLR, TVR, and restenosis were significantly lower in DES group, with OR 0.77(95%CI 0.59-0.99, P=0.04), 0.48(95%CI 0.41-0.56, P<0.00001), 0.74(95%CI 0.55-0.98, P=0.04), 0.51(95%CI: 0.26-0.98, P=0.04), 0.24(95%CI: 0.16-0.37, P<0.00001), 0.47(95%CI: 0.38-0.59, P<0.00001), and 0.24 (95%CI 0.14-0.43, P<0.00001), respectively.Conclusion: Compared with BMS, DES had lower rates of adverse clinical outcomes, and restenosis during long-term follow-up.Nepalese Heart Journal 2018; 15(1): 1-7

scholarly journals The efficacy of bare metal stent implantation for patients with acute myocardial infarction in the drug-eluting stent era

2008 ◽  
Vol 51 (3) ◽  
pp. 189-195 ◽  
Author(s):  
Hajime Fujimoto ◽  
Susumu Tao ◽  
Jun Masuda ◽  
Haruo Mitani ◽  
Sachiko Ito ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Stent Implantation ◽  
Bare Metal Stent ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Drug Eluting

scholarly journals Risks of Recurrent Cardiovascular Events and Mortality in 1-Year Survivors of Acute Myocardial Infarction Implanted with Newer-Generation Drug-Eluting Stents

2021 ◽  
Vol 10 (16) ◽  
pp. 3642
Author(s):  
Sungmin Lim ◽  
Eun Ho Choo ◽  
Ik Jun Choi ◽  
Kwan Yong Lee ◽  
Su Nam Lee ◽  
...  
Keyword(s):  
Risk Factors ◽  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Clinical Outcomes ◽  
Cardiovascular Events ◽  
Drug Eluting Stents ◽  
Index Procedure ◽  
Drug Eluting ◽  
Traditional Risk Factors

Current treatments for acute myocardial infarction (AMI) have dramatically improved clinical outcomes during the first year after AMI. Less is known, however, about the subsequent risks of recurrent cardiovascular events and mortality in patients who survive 1 year after AMI. The purpose of the present study is to evaluate long-term clinical outcomes in 1-year AMI survivors who were implanted with newer-generation drug-eluting stents (DESs) since 2010. The COREA-AMI (CardiOvascular Risk and idEntificAtion of potential high-risk population in AMI) registry consecutively enrolled AMI patients who underwent percutaneous coronary intervention (PCI), and patients who received newer-generation DESs since 2010 were analyzed. The primary endpoint was major adverse cardiovascular events (MACEs), and secondary endpoint was all-cause mortality. Of 6242 AMI patients, 5397 were alive 1 year after the index procedure. The cumulative incidence of MACEs and all-cause death 1 to 7 years after AMI were 28.4% (annually 4–6%) and 20.2% (annually 3–4%), respectively. Multivariate analysis showed that uncontrolled systolic blood pressure (SBP) and serum low-density lipoprotein cholesterol (LDL-C) concentration, as well as traditional risk factors, were associated with MACEs and all-cause death. Recurrent non-fatal myocardial infarction, ischemic stroke, and bleeding events within 1 year were significantly associated with all-cause death. The risks of adverse cardiovascular events and death remain high in AMI patients more than 1 year after the index PCI with newer-generation DESs. Traditional risk factors, uncontrolled SBP and LDL-C, and non-fatal adverse events within 1 year after the index procedure strongly influence long-term clinical outcomes.

Long-term outcome of sirolimus-eluting vs bare-metal stent in the setting of acute myocardial infarction: 5-year results of the SESAMI trial

2013 ◽  
Vol 166 (2) ◽  
pp. 399-403 ◽  
Author(s):  
Carmine Musto ◽  
Rosario Fiorilli ◽  
Francesco De Felice ◽  
Giuseppe Patti ◽  
Marco Stefano Nazzaro ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Bare Metal Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Term Outcome ◽  
Long Term Outcome
Sign in / Sign up

Export Citation Format

Share Document